In this video, Ruben A. Mesa, MD, director of the Mays Cancer Center, discusses strategies for navigating the expanding paradigm of JAK inhibitors in myeloproliferative neoplasms.
Newsroom
In this video, Ruben A. Mesa, MD, director of the Mays Cancer Center, discusses strategies for navigating the expanding paradigm of JAK inhibitors in myeloproliferative neoplasms.